Back to funds
View filing
Octagon Capital Advisors LP
hedge fundUpdated 27 days agoManaged by Octagon Capital Advisors Lp • Latest filing Q2 2026
Portfolio value
$1.1B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
97.9%
Weight of largest holdings
Annualized return
-7.4%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $695M |
| Q2 2023 | $718.7M |
| Q3 2023 | $650.9M |
| Q4 2023 | $625M |
| Q1 2024 | $834.4M |
| Q2 2024 | $636.3M |
| Q3 2024 | $642.9M |
| Q4 2024 | $607.7M |
| Q1 2025 | $516.8M |
| Q2 2025 | $455.6M |
| Q3 2025 | $659.8M |
| Q4 2025 | $823.7M |
| Q1 2026 | $903.6M |
| Q2 2026 | $1.1B |
Top holdings
27 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | D DNTH DIANTHUS THERAPEUTICS INC | $179.5M | 1.84M | 16.14% | — |
| 2 | D DFTX DEFINIUM THERAPEUTICS INC | $138.8M | 2.95M | 12.47% | — |
| 3 | A AAVXF ABIVAX SA | $132.3M | 993.0K | 11.89% | — |
| 4 | C COGT COGENT BIOSCIENCES INC | $90.9M | 2.35M | 8.17% | — |
| 5 | A ALMS ALUMIS INC | $79.7M | 2.83M | 7.16% | — |
| 6 | ? N/A ARRIVENT BIOPHARMA INC | $68.5M | 1.97M | 6.15% | — |
| 7 | T TSHA TAYSHA GENE THERAPIES INC | $66M | 9.69M | 5.93% | — |
| 8 | ? N/A BIOAGE LABS INC | $42.8M | 1.75M | 3.85% | — |
| 9 | M MIRM MIRUM PHARMACEUTICALS INC | $39.7M | 338.9K | 3.57% | — |
| 10 | K KYMR KYMERA THERAPEUTICS INC | $35.5M | 310.0K | 3.20% | — |
| 11 | A AKTS AKTIS ONCOLOGY INC | $31M | 960.8K | 2.78% | — |
| 12 | X XENE XENON PHARMACEUTICALS INC | $29.6M | 490.0K | 2.66% | — |
| 13 | ? N/A ERASCA INC | $23M | 1.25M | 2.07% | — |
| 14 | ? N/A PALISADE BIO INC | $21.5M | 10.28M | 1.93% | — |
| 15 | O OCFC OCULAR THERAPEUTIX INC | $20.4M | 2.08M | 1.83% | — |
| 16 | I IRON DISC MEDICINE INC | $19.7M | 270.0K | 1.77% | — |
| 17 | S SMMT SUMMIT THERAPEUTICS INC | $18.2M | 1.25M | 1.64% | — |
| 18 | P PHVS PHARVARIS N V | $15.8M | 456.7K | 1.42% | — |
| 19 | A ANL ADLAI NORTYE LTD | $10.7M | 934.7K | 0.97% | — |
| 20 | D DTIL PRECISION BIOSCIENCES INC | $10.6M | 1.35M | 0.95% | — |